FAM3A is a mitochondrial protein that functions as a metabolic regulator with diverse physiological roles. The protein primarily acts to enhance cellular energy metabolism by promoting ATP synthesis through increased ATP synthase activity and activating the PKB-CREB-FOXD3-ATP synthase regulatory loop 1. FAM3A mediates ATP release through PANX1 channels, which activates P2 receptor pathways to suppress hepatic gluconeogenesis and lipogenesis via the Akt-FOXO1 pathway 2. In pancreatic α-cells, FAM3A regulates proglucagon processing by controlling the Nr4a2-Foxa2-PC1/3 pathway, thereby modulating GLP-1 production and glucose homeostasis 3. The protein exhibits protective effects against cellular stress by activating PI3K/AKT/NRF2 signaling pathways, reducing mitochondrial ROS accumulation, and inhibiting pyroptosis in conditions like acute kidney injury 4. FAM3A also influences vascular smooth muscle cell differentiation in abdominal aortic aneurysm by regulating KLF4 ubiquitination 5. Transcriptionally, FAM3A is regulated by C/EBPβ and inhibits adipocyte differentiation 6. Clinical relevance includes potential therapeutic applications in ischemic diseases, metabolic disorders, and vascular pathologies, with FAM3A levels being altered in various disease states including gestational diabetes mellitus 7.